Ultrasound-Accelerated Thrombolysis and Venoplasty for the Treatment of the Postthrombotic Syndrome: Results of the ACCESS PTS Study

被引:20
作者
Garcia, Mark J. [1 ]
Sterling, Keith M. [2 ]
Kahn, Susan R. [4 ,5 ]
Comerota, Anthony J. [3 ]
Jaff, Michael R. [6 ]
Ouriel, Kenneth [7 ]
Weinberg, Ido [8 ]
机构
[1] Endo Vasc Consultants, Wilmington, DE USA
[2] Nova Alexandria Hosp, Dept Cardiovasc & Intervent Radiol, Alexandria, VA USA
[3] Nova Alexandria Hosp, Nova Heart & Vasc Inst, Alexandria, VA USA
[4] McGill Univ, Div Internal Med, Montreal, PQ, Canada
[5] McGill Univ, Ctr Clin Epidemiol, Jewish Gen Hosp, Dept Med, Montreal, PQ, Canada
[6] Newton Wellesley Hosp, Newton, MA USA
[7] Syntactx, New York, NY USA
[8] Massachusetts Gen Hosp, Vasc Ultrasound Core Lab, VasCore, Boston, MA 02114 USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2020年 / 9卷 / 03期
关键词
deep vein thrombosis; pharmacomechanical thrombectomy; postthrombotic syndrome; ultrasound-accelerated thrombolysis; CATHETER-DIRECTED THROMBOLYSIS; DEEP-VEIN THROMBOSIS; VENOUS THROMBOSIS; DETERMINANTS; THERAPY; CAVENT;
D O I
10.1161/JAHA.119.013398
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Postthrombotic syndrome is a common complication of deep vein thrombosis, with limited treatment options. Methods and Results ACCESS PTS (Accelerated Thrombolysis for Post-Thrombotic Syndrome Using the Acoustic Pulse Thrombolysis Ekosonic Endovascular System) is a multicenter, single-arm, prospective study evaluating patients with chronic deep vein thrombosis and postthrombotic syndrome (Villalta score >= 8) who received minimum 3 months of anticoagulation. Patients underwent percutaneous transluminal venoplasty and ultrasound-accelerated thrombolysis, with data collected on clinical characteristics, postthrombotic syndrome, imaging, and quality of life to 1 year. The primary efficacy outcome was a reduction of >= 4 points in the Villalta score 30 days after procedure. The primary safety outcomes were major bleeding episodes within 72 hours and symptomatic pulmonary embolism during the index hospitalization. A total of 82 limbs (78 patients) were treated (age, 54.6 +/- 12.7 years; 32.1% women; mean Villalta score, 15.5 +/- 5.2). The primary end point was met in 64.6% (51/79). At 1 year, 77.3% (51/66) of limbs continued with a Villalta reduction >= 4. At 365 days, >90% of segments had patency with ultrasound flow present. Baseline to 1-year Physical Component Summary mean score of the Short Form-36 increased from 38.9 +/- 9.5 to 45.2 +/- 9.8 (P <= 0.0001), and mean VEINES-QOL (Venous Insufficiency Epidemiological and Economic Study-Quality of Life) increased from 61.9 +/- 19.7 to 82.6 +/- 20.8 at 1 year (P<0.0001). Iliofemoral venous stenting was performed in 42 patients, with similar improvements seen in all outcomes, regardless of stenting status. One patient developed severe bleeding within 72 hours of the intervention and died at 32 days after procedure (1.3% mortality rate). Conclusions Percutaneous transluminal venoplasty and ultrasound-accelerated thrombolysis resulted in successful recanalization of chronic venous obstruction with improved postthrombotic syndrome severity and quality of life. Results were sustained at 1-year after procedure.
引用
收藏
页数:10
相关论文
共 27 条
[21]   Catheter-directed thrombolysis for lower extremity deep venous thrombosis: Report of a national multicenter registry [J].
Mewissen, MW ;
Seabrook, GR ;
Meissner, MH ;
Cynamon, J ;
Labropoulos, N ;
Haughton, SH .
RADIOLOGY, 1999, 211 (01) :39-49
[22]   Postthrombotic Syndrome: Feasibility of a Strategy of Imaging-guided Endovascular Intervention [J].
Nayak, Lina ;
Hildebolt, Charles F. ;
Vedantham, Suresh .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2012, 23 (09) :1165-1173
[23]   Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients [J].
Schulman, S ;
Kearon, C .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (04) :692-694
[24]  
Tachibana K., 1996, ULTRASOUND ANGIOPLAS, P121
[25]   The impact of venous thrombosis on quality of life [J].
van Korlaar, IM ;
Vossen, CY ;
Rosendaal, FR ;
Bovill, EG ;
Cushman, M ;
Naud, S ;
Kaptein, AA .
THROMBOSIS RESEARCH, 2004, 114 (01) :11-18
[26]   Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis [J].
Vedantham, S. ;
Goldhaber, S. Z. ;
Julian, J. A. ;
Kahn, S. R. ;
Jaff, M. R. ;
Cohen, D. J. ;
Magnuson, E. ;
Razavi, M. K. ;
Comerota, A. J. ;
Gornik, H. L. ;
Murphy, T. P. ;
Lewis, L. ;
Duncan, J. R. ;
Nieters, P. ;
Derfler, M. C. ;
Filion, M. ;
Gu, C. -S. ;
Kee, S. ;
Schneider, J. ;
Saad, N. ;
Blinder, M. ;
Moll, S. ;
Sacks, D. ;
Lin, J. ;
Rundback, J. ;
Garcia, M. ;
Razdan, R. ;
VanderWoude, E. ;
Marques, V. ;
Kearon, C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (23) :2240-2252
[27]   Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel [J].
Vedantham, Suresh ;
Kahn, Susan R. ;
Goldhaber, Samuel Z. ;
Comerota, Anthony J. ;
Parpia, Sameer ;
Meleth, Sreelatha ;
Earp, Diane ;
Williams, Rick ;
Sista, Akhilesh K. ;
Marston, William ;
Rathbun, Suman ;
Magnuson, Elizabeth A. ;
Razavi, Mahmood K. ;
Jaff, Michael R. ;
Kearon, Clive .
VASCULAR MEDICINE, 2016, 21 (04) :400-407